Skip to content

Rafael Holdings, Inc. RFL Cash & Equivalents

Cash & Equivalents at other companies

Intel logo
IntelINTC
$17.25B+92.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$21.69B-43.6%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$95.6M+156%
Mobileye Global Inc. logo
Mobileye Global Inc.MBLY
$1.21B-19.9%
Polaryx Therapeutics, Inc.
 logo
Polaryx Therapeutics, Inc. PLYX
$3.08M+1,132%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$56.4M+14.3%

Other financials

Income statement

See full
Revenue$179.0K-50.6%
Gross profit$131.0K-56.3%
Operating income-$6.9M-16.2%
Net income-$4.2M+11.6%
EPS (diluted)-$0.08+57.9%

Balance sheet

See full
Total debt$21.9M+995%
Total equity$75.4M-6.4%
Total assets$92.0M-14.9%

Cash flow

See full
Operating cash flow-$7.3M-128%
CapEx$6.0K
Free cash flow-$7.3M-128%

Valuation

See full
Market cap$170.56M+189%
P/S174×+93.5×

Profitability

See full
Gross margin71.9%
Operating margin-3,717.2%+1,952pp
Net margin-2,117.2%-517pp
FCF margin-2,064.1%

Returns & leverage

See full
Return on equity-26.6%-0.8pp
Debt / equity0.3×+0.2×
Current ratio3.2×-0.7×

Where this comes from

Reported directly by Rafael Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Rafael Holdings, Inc.’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rafael Holdings, Inc.'s cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rafael Holdings, Inc.'s cash & equivalents?
Rafael Holdings, Inc. (RFL) reported cash & equivalents of $30.5M in Q1 2026.
How has Rafael Holdings, Inc.'s cash & equivalents changed year-over-year?
Rafael Holdings, Inc.'s cash & equivalents decreased by 19.6% year-over-year, from $37.94M to $30.5M.
What is the long-term trend for Rafael Holdings, Inc.'s cash & equivalents?
Over 4 years (2021 to 2025), Rafael Holdings, Inc.'s cash & equivalents has grown at a 42.3% compound annual growth rate (CAGR), from $12.85M to $52.77M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.